Custom Health Holdings Inc. (CHLT.TO) is making waves on the TSX with a notable increase in its stock price.
In the latest trading session, Custom Health Holdings Inc. saw its stock price rise by 2.52%, closing at CA$6.50. This uptick comes amidst a backdrop of strategic acquisitions and a growing revenue outlook, positioning the company for potential growth in the healthcare sector.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Custom Health Holdings Inc.
CHLT.TO
CHLT.TO
Custom Health Holdings Inc.
WealthAwesomeMarket cap
$158.98M
52W high
$11.00
52W low
$5.25
1W change
-1.45%
Analyst Price Targets
Based on analyst covering CHLT
Wall Street analysts forecast CHLT stock price to rise 76.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$12.00
+76.5% Upside
Current Price
C$6.80
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Investor takeaway: For Canadian investors, Custom Health Holdings Inc. represents a promising opportunity in the healthcare market, especially given its recent operational advancements and revenue growth.
Custom Health Holdings Inc. Gains 2.52% in One Day
With a market cap of CA$163.89 million, CHLT.TO's stock performance reflects growing investor confidence following strategic acquisitions.
Bull case
The company recently completed a plan of arrangement and acquired InnovativeRx subsidiaries, laying a strong foundation for future growth. These steps could boost revenue and expand its market presence.
Bear case
Despite the positive movement, investors should be cautious. The company has not yet established a consistent profit margin, and its P/E ratio is currently not applicable.
Recent Performance
Advertisement
Custom Health Holdings Inc. has shown strong performance in the latest trading session, with a 2.52% increase in stock price, closing at CA$6.50. This positive movement reflects investor confidence in the company's recent strategic initiatives.
Strategic Acquisitions
The recent completion of the plan of arrangement and the acquisition of InnovativeRx operating subsidiaries are pivotal for Custom Health. These moves are expected to enhance the company's integrated medication management infrastructure, positioning it for future growth in the healthcare sector.
Looking Ahead
As Custom Health continues to expand its operations and revenue potential, investors should keep an eye on its financial performance and market developments. For more insights on Custom Health Holdings Inc., check out our detailed analysis on CHLT.TO.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
